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Clostridium encompasses species which are relevant to human and animal disease as well as species
which have industrial potential, for instance, as producers of chemicals and fuels or as tumour delivery
vehicles. Genetic manipulation of these target organisms is critical for advances in these ﬁelds. DNA
transfer efﬁciencies, however, vary between species. Low efﬁciencies can impede the progress of research
efforts.
A novel conjugal donor strain of Escherichia coli has been created which exhibits a greater than 10-fold
increases in conjugation efﬁciency compared to the traditionally used CA434 strain in the three species
tested; C. autoethanogenum DSM 10061, C. sporogenes NCIMB 10696 and C. difﬁcile R20291. The novel
strain, designated ‘sExpress’, does not methylate DNA at Dcm sites (CCWGG) which allows circumvention
of cytosine-speciﬁc Type IV restriction systems.
A robust protocol for conjugation is presented which routinely produces in the order of 105 trans-
conjugants per millilitre of donor cells for C. autoethanogenum, 106 for C. sporogenes and 102 for C. difﬁcile
R20291. The novel strain created is predicted to be a superior conjugal donor in a wide range of species
which possess Type IV restriction systems.
© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The bacterial genus Clostridium is most often associated with
disease, none more so than Clostridium difﬁcile, the leading cause of
antibiotic-associated disease and a signiﬁcant burden on the ﬁ-
nances of healthcare systems worldwide [1]. However, the vast
majority of clostridial species are entirely benign and in many in-
stances possess properties and attributes of great beneﬁt to
mankind. The acetogen Clostridium autoethanogenum, for instance,
is the chassis currently being commercialised by LanzaTech for the
large-scale conversion of the CO/H2-rich waste streams of steel millup, BBSRC/EPSRC Synthetic
nces, The University of Not-
.P. Minton).
r Ltd. This is an open access articleoff-gas into ethanol for use as a transportation fuel [2]. On the other
hand, Clostridium sporogenes is being pursued as a vehicle for the
delivery of anti-cancer agents to solid tumours [3].
Gene modiﬁcation and/or bioengineering offer one of the most
effective routes to either a better understanding of the molecular
pathogenesis of an organism, or to bring about essential improve-
ments to those chassis with commercial potential. Crucial is the
ability to efﬁciently introduce the requisite gene tools into the
target clostridial cell. DNA transfer is routinely achieved in Clos-
tridium species via either electrotransformation or by conjugative
mobilisation from an Escherichia coli donor strain [4]. Conjugation
is the preferred method of DNA transfer in many species, for
instance Clostridium autoethanogenum [5], Clostridium botulinum
[6], Clostridium sporogenes [7], and Clostridium difﬁcile [8]. None-
theless, in many of these species the frequencies of transfer are
relatively low. This is particularly the case with C. autoethanogenum
and many strains of C. difﬁcile, in particular so-called hypervirulentunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. A comparison of conjugation efﬁciency using either the DCLAU_0514 strain of C.
autoethanogenum DSM 10061 (IIG deﬁcient) or the wild type strain as the recipient.
sExpress was used as a conjugal donor in either case with the only difference in
conjugation protocol being the choice of recipient strain. Error bars show the standard
deviation. An unpaired two-tailed T-test was performed with Welch's correction to
measure the signiﬁcance of the difference between the two recipient strains giving a P
value of <0.0001, n¼ 4. Four different recipient cultures were used for each condition
with optical densities ranging from 0.1 to 0.2. Colony forming units (CFU) ml1 was
calculated as the number of colony forming units per ml of recipient culture using
200 ml of conjugal donor culture per conjugation.
C. Woods et al. / Anaerobe 59 (2019) 184e191 185strains belonging to PCR Ribotype 027 [9]. .
There are a variety of E. coli strains which are capable of medi-
ating the mobilisation of small, autonomous vectors to clostridial
recipients during the process of conjugation. Transfer of the vector
generally relies on its oriT-mediated mobilisation with the neces-
sary transfer functions being provided in trans by genes located
either on a plasmid, such as R702, co-resident in the donor E.coli
host strain (eg., CA434), or in the chromosome, e.g. donor strains
S17.1 and SM10 [4]. All genetic studies of C. autoethanogenum to
date, and the majority of studies in C. difﬁcile and C. sporogenes,
have used the donor E. coli strain CA434 [10].
One prominent barrier to transformation is that of host
restriction-modiﬁcation (RM) systems. Restriction systems degrade
incoming DNA which lacks the native modiﬁcations of the target
strain and is hence recognised as ‘foreign’. DNA can be regarded as
foreign if an expected modiﬁcation at a given motif is absent, or
where additional modiﬁcations which are typically not found in
native DNA are present. Type IV restriction systems are charac-
terised as those which recognise foreign modiﬁcation patterns,
whilst Types I-III target unmodiﬁed DNA. The three species
examined here (C. autoethanogenum, C, sporogenes and C. difﬁcile)
are uniﬁed by possessing Type IV restriction systems.
The methylation status of the donor strain has been shown to
affect DNA transfer efﬁciencies in a range of bacterial species
including Bacillus anthracis [11], Streptomyces [12,13], Bacillus
thuringiensis [14], Acholeplasma laidlawii [15], Streptomyces aver-
militis [16] and Lactobacillus [17]. More recently, several studies on
clostridia have come to similar conclusions concerningmethylation
status including C. thermocellum DSM 1313 [18], C. ljungdahlii DSM
13528 [19], and C. pasteurianum NRRL B-598 [20]. In this study the
derivation and application of a novel conjugal E. coli donor strain
designated ‘sExpress’, which lacks Dcm methylation, is described.
sExpress offers a signiﬁcant increase in conjugation efﬁciency over
the previously widely used CA434.
2. Results
2.1. Restriction systems of C. autoethanogenum DSM 10061
The restriction enzyme database http://rebase.neb.com [21]
provides an overview of the restriction-modiﬁcation (RM) systems
found in the genome of a given strain. The REBASE proﬁle of
C. autoethanogenum DSM 10061 predicts ﬁve genes to be Type IV
restriction enzymes each with an unknown recognition sequence.
The attribution of these genes as encoding Type IV systems is due to
a shared region of homology with the E. coliMcrB Type IV cytosine-
speciﬁc restriction enzyme. McrB is the cytosine-speciﬁc binding
component of the McrB-McrA complex [22]. C. autoethanogenum
DSM 10061 is also predicted to possess four methyltransferase
genes, one of which is a Type II restriction-modiﬁcation enzyme
(Cau10061II) which has a predicted methylation motif of ‘GTTAAT’.
The other three methyltransferases appear to have no associated
restriction enzymes and so are not expected to signiﬁcantly
contribute to a restriction barrier. Initially, our research aimed to
increase the efﬁciency of DNA transfer to C. autoethanogenum DSM
10061. To achieve this the two most promising approaches
appeared to be to generate a knockout of the fused R-M system
Cau10061II encoded by CLAU_0514 and to circumvent the effects of
the ﬁve Type IV system enzymes by removing Dcm methylation
from the incoming DNA.
2.2. C. autoethanogenum DCLAU_0514 exhibits an increased
conjugation efﬁciency
CLAU_0514 encodes a fused Type II R-M enzyme which REBASEpredicts to have a sequence speciﬁcity of GTTAAT. A knockout strain
for this gene was created in a wild type C. autoethanogenum DSM
10061 background with the aim of creating a strain which is more
amenable to DNA transfer. The knockout was generated through
CRISPR/Cas9-mediated genome editing [23]. The requisite knock-
out plasmid, pMTL43151-CLAU_0514, was constructed as detailed
in the methods section. This vector consists of homology arms
targeting the CLAU_0514 locus, causing a clean and complete
deletion following a double homologous recombination event. The
knockout vector was introduced into C. autoethanogenum DSM
10061 via conjugation and colonies representing putative mutants
were analysed via colony PCR. Sanger sequencing of the colony PCR
products was used to conﬁrm a successful deletion. After conﬁr-
mation of the deletion, a conjugation efﬁciency experiment was
undertaken as detailed in the methods section. The donor strain
whose creation is detailed in this text ‘sExpress’ was used to
transfer the plasmid pMTL83151 which harbours a thiamphenicol
resistance cassette. The newly createdDCLAU_0514 strain showed a
statistically signiﬁcant (p¼ <0.0001) increase in the number of
transconjugants obtained from conjugation (Fig. 1).2.3. Derivation of the novel strain ‘sExpress’ donor strain
CA434 is essentially E. coli HB101 carrying R702, and contains
both Dam and Dcm methyltransferases which modify the se-
quences GATC and CCWGG, respectively. To circumvent the Type IV
restriction systems of C. autoethanogenum DSM 10061, a strain
which does not methylate at Dcm (CCWGG) sites was required. NEB
Express (fhuA2 [lon] ompT gal sulA11 R(mcr-73:miniTn10–TetS)2
[dcm] R(zgb-210:Tn10–TetS) endA1 D(mcrC-mrr)114:IS10) is a
commercially available strainwhich ﬁt the requirements to become
the basis of our novel conjugal donor, most notably the lack of Dcm
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on the plasmid R702. Since R702 is self-mobilisable, the construc-
tion of a novel conjugal donor strain was achieved via conjugative
plasmid transfer of R702 from CA434 (donor) to the chosen recip-
ient strain, NEB Express. CA434 carries both a leuB6 and a proA2
mutation. R702 confers resistance to tetracycline. CA434 was,
therefore, counter-selected on M9 salts minimal medium lacking
proline and leucine while transconjugants (NEB Express harbour-
ing R702) were positively selected by the incorporation of tetra-
cycline into the selective media. Transconjugants were re-streaked
and the acquisition of the R702 vector conﬁrmed by PCR and sub-
sequent Sanger sequencing. The resulting strain was designated
‘sExpress’.Fig. 2. A comparison of conjugation efﬁciency varying the conjugal donor strain. A
single recipient culture was used for both donor strains. Ten separate donor cultures
were used in separate conjugations for each donor strain. pMTL83151 was the target
plasmid transferred in each case. Error bars represent the standard deviations of each
dataset. Two-tailed T-tests using Welch's correction were used to compare the two
donor strains (p ¼ 0.0071 **, n ¼ 10).2.4. sExpress is a superior donor strain to CA434 in
C. autoethanogenum DSM 10061
C. autoethanogenum DSM 10061 was used as a recipient in
conjugations with the donor strains CA434 or sExpress into which
had been introduced the plasmid pMTL83151. This is a modular
vector [24] which forms the basis for many vectors commonly used
in C. autoethanogenum. The plasmid pMTL83151 contains a Gram-
positive origin of replication from the C. butyricum plasmid
pCB102 and the C. perfringens catP antibiotic resistance marker that
confers resistance to thiamphenicol on clostridial hosts. It was
chosen as the representative plasmid to be transferred due to the
widespread use of this replicon in genetic studies of
C. autoethanogenum as well as the generally higher frequencies of
transfer which have been noted compared to other Gram-positive
origins of replication. It contains nine Dcm sites (CCWGG) which
would be methylated in the CA434 strain. The conjugation protocol
used to directly compare the two donor strains is detailed in the
materials and methods section, with the sole difference being the
identity of the donor strain. sExpress produced an average of 9991
(SD¼ 4782) transconjugants per conjugation whilst CA434 gener-
ated an average of 21 (SD¼ 16). In terms of efﬁciency per donor cell
this represented values of 1.057 (SD¼ 1.587) for CA434 and
7.945 (SD¼ 7.235) for sExpress (Fig. 2).Fig. 3. A comparison of conjugation efﬁciency between two donor strains (CA434 and
sExpress) into two different C. sporogenes NCIMB 10696 recipient strains. C. sporogenes
DCLSPO_c06750 is a knockout strain for a putative Type IV restriction system. Three
recipient strain cultures were grown of both wild type and DCLSPO_c06750 and each
of these strains was used in three separate conjugations from separate donor strain
cultures. This gave a total of nine conjugations for each donor/recipient combination.
Conjugation efﬁciency was calculated as the ratio of CFU on transconjugant selective
plates to the CFU of donor cells going into each conjugation. There was a signiﬁcant
difference in conjugation efﬁciency between CA434 and sExpress in wild type
C. sporogenes (p ¼ 0.0003 ***, n ¼ 9) and between the wild type and knockout strain
when using CA434 (p ¼ 0.0008 ***, n ¼ 9) but not when using sExpress. There was no
statistically signiﬁcance difference in conjugation efﬁciency between CA434 and sEx-
press in the DCLSPO_c06750 strain (p ¼ 0.0684, n ¼ 9). Two-tailed T-tests using
Welch's correction were used in each comparison.2.5. sExpress in C. sporogenes
Having established sExpress as a superior conjugal donor strain
in conjugations with C. autoethanogenum, an analysis of related
organisms for which the strain could prove beneﬁcial was under-
taken. The presence of a Type IV restriction system, as predicted by
REBASE, was indicative that sExpress would be beneﬁcial. One or-
ganism highlighted by the analysis was C. sporogenes NCIMB 10696
[25]. The transfer frequency into C. sporogenes using CA434 was
already sufﬁciently high and the protocol sufﬁciently robust that
standard genetic studies could proceed unhampered. However, if
sufﬁciently high frequencies of transfer could be obtained in this
organism then it would be an important step towards imple-
mentation of several high throughput techniques such as Multiplex
Automated Genomic Engineering (MAGE) [26] or Transposon
Directed Insertion Sequencing (TraDIS) [27]. With this in mind, the
two donors CA434 and sExpress were compared as for
C. autoethanogenum. The use of sExpress in C. sporogenes NCIMB
10696 improved conjugation efﬁciencies by approximately one
order of magnitude (Fig. 3). To further investigate the effects of
Type IV restriction systems on DNA transfer to C. sporogenes NCIMB
10696 a knockout strain for a putative Type IV restriction system
was created and the conjugation efﬁciency of both CA434 and
sExpress was measured in this strain.2.6. Knocking out the type IV restriction system of C. sporogenes
C. sporogenes NCIMB 10696 has only a single Type IV restriction
enzyme predicted by REBASE. To further investigate the improved
transfer when using sExpress as the conjugal donor a knockout
strain of C. sporogenes NCIMB 10696 for the putative Type IV re-
striction system gene CLSPO_c06750 encoding Csp10696ORF6750P
was generated. According to CD-Search (NCBI), the protein encoded
by this gene contains several conserved domains in common with
Type IV restriction enzyme SauUSI, which is known to cleave
Fig. 4. Comparative efﬁciencies of conjugative plasmid transfer of various vectors from
the E. coli donors CA434 and sExpress into the recipient strain C. difﬁcile R20291. The
indicated plasmids, along with a control pMTL80000 plasmid lacking a functional
Gram-positive replicon, were transferred from either donor using the conjugation
method outlined in the materials and methods section. Conjugation efﬁciency was
calculated as the proportion of putative transconjugant thiamphenicol resistant col-
onies divided by the CFU of recipient cells. Bars represent the means of three separate
conjugations with error bars representing standard deviation. Statistical signiﬁcance
was determined using multiple unpaired t-tests, with one asterisk denoting a (p < 0.05
*, n ¼ 3).
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If the improved transfer frequencies when using sExpress
compared to CA434 were solely due to the circumvention of the
Type IV restriction system then it would be expected that transfer
frequencies from CA434 into the C. sporogenes DCLSPO_c06750
strain should be equivalent to those from sExpress into the wild
type. This is due to the fact that sExpress should only prove bene-
ﬁcial due to the avoidance of restriction from the C. sporogenes
NCIMB10696 Type IV restriction system which will attack DNA
from the CA434 donor but not from sExpress. If CLSPO_c06750
encodes the only Type IV restriction enzyme in the C. sporogenes
genome then the advantage sExpress has over CA434 for this strain
should be removed. The△CLSPO_c06750 C. sporogenes strain was
created by ﬁrst generating a ClosTron mutant which was subse-
quently converted to a clean deletion using CRISPR/Cas9 genome
editing. Although the ClosTron mutants presented increased
conjugation efﬁciencies when compared to the wild type strain
(data not shown), a clean deletion of the gene was desirable to rule
out the possibility of this phenomenon being due to polar effects of
the insertion. To achieve this, an in frame deletion of the
CLSPO_c06750 gene was obtained using a CRISPR/Cas9 essentially
using a previously described system [23]. In this case the ClosTron
insertion of the previously created CLSPO_c06750-1241a:CT strain
was the target of the sgRNA converting the ClosTronmutant to an in
frame deletion mutant. The construction of mutants is detailed in
the materials and methods section.
The transfer efﬁciency of CA434 into the△CLSPO_c06750 strain
is similar to the transfer rate of sExpress into wild type
C. sporogenes NCIMB 10696 (Fig. 3). sExpress offers no advantage
over CA434 in the Type IV knockout strain implying that the
advantage it offers in the WT strain is solely due to the lack of Dcm
methylation.
2.7. sExpress in a PCR ribotype 027 C. difﬁcile strain, R20291
PCR Ribotype (RT) 027 strains have historically been associated
with more severe disease, increased mortality, higher relapse rates
and increased resistance to ﬂuoroquinolone antibiotics [1]. As a
consequence, they are frequently referred to as ‘hyper-virulent’ [9].
RT 027 strains ﬁrst came to prominence at the turn of this century
in North America where they were responsible for dramatic in-
creases in C. difﬁcile infection (CDI) rates in Canada [1]. Shortly
thereafter, their arrival in the UK was signalled by two serious CDI
outbreaks at Stoke Mandeville hospital in 2003 and again in 2005
[29]. During these two outbreaks, a total of 498 cases were reported
with 172 deaths [29]. The strain responsible was R20291, which has
gone on to become a model for RT 027 strains [30].
In common with other RT 027 strains, the frequency of plasmid
transfer into R20291 in conjugations with CA434 is low. Given the
presence of predicted Type IV restriction systems it was hypoth-
esised that the sExpress conjugal donor strain could increase fre-
quencies of conjugation as previously observed in the other two
clostridial species examined in this study. Fig. 4 demonstrates that
sExpress offers signiﬁcantly increased frequency of conjugative
plasmid transfer of a range of vectors, based on different clostridial
replicons, into C. difﬁcile R20291 compared to the use of CA434 as
the donor. In the one instance, pMTL85151 (which carries the
pIM13 Gram-positive replicon), transfer could not be demonstrated
using CA434 as the donor strain. In contrast, using sExpress as the
donor, R20291 transconjugants were reproducibly obtained.
Exposing the recipient C. difﬁcile cells to heat shock prior to
mixing with donor E. coli cells has previously been shown to in-
crease conjugation efﬁciencies [31]. One possible explaination for
the increasewas suggested to be due to the inactivation of C. difﬁcile
restriction systems. To investigate this idea the published heatshock protocol was followed using both CA434 and sExpress as
donors (Fig. 5). Our results show that the advantage of sExpress as a
donor was retained even with heat shock, suggesting that it is not
the Type IV restriction systemwhich sExpress circumvents which is
being inactivated by the heat shock, though other restriction sys-
tems may be.3. Discussion
In the current study we have demonstrated that E. coli sExpress
represents a superior conjugal donor for the transfer of plasmids to
the clostridial recipient strains C. autoethanogenum DSM 10061,
C. sporogenes NCIMB 10696 and C. difﬁcile R20291 compared to the
E.coli donor strain CA434. For C. autoethanogenum DSM 10061 it is
worth noting that of the ten separate conjugations performed only
six produced any transconjugants when using CA434 as the con-
jugal donor. Historically, this lack of reproducible plasmid transfer
has inevitably slowed progress in strategies reliant on genetic
modiﬁcation of the strain, a situation exacerbated by the extended
period of time required for the development of transconjugant
colonies, which typically arise on day 6 of the process. The unreli-
ability of conjugative transfer using CA434 as the donor has
necessitated setting up multiple conjugation replicates. These in-
efﬁciencies are compounded by further decreases in efﬁciencies
when using plasmids larger than pMTL83151 or when using a more
defective Gram-positive replicons than pCB102 as is preferred
when genome editing following the Allele-Coupled Exchange (ACE)
procedure [32,33].
A knockout strain for CLAU_0514; which encodes a putative
Type IIG fused restriction-modiﬁcation enzyme was generated via
CRISPR-Cas9. The resultant strain exhibited one order of magnitude
higher conjugation efﬁciencies over the wild type providing ﬁrm
evidence for the relevance of this enzyme to the restriction barrier
in C. autoethanogenum DSM 10061. This strain could be useful for
studies for which a high DNA transfer rate is required. More beneﬁt
was derived from the generation of the sExpress donor strain,
however, which produced approximately 600 times the number of
transconjugants per conjugation than CA434 (Fig. 2) and can be
used with the wild type strain of C. autoethanogenum DSM 10061.
Fig. 5. Determination of conjugation efﬁciency into C. difﬁcile R20291 using the Kirk et al. protocol. E. coli donors CA434 or Sexpress were used to transfer plasmid pMTL84151 into
C. difﬁcile R20291 following 8 or 24 h (h) incubation on mating plates, with (HT) or without (N) prior heat-treatment of recipient R20291 cells. This experiment utilised the Kirk et al.
[31]method of conjugative transfer. Brieﬂy, C. difﬁcile R20291 recipient cells were grown overnight in TY broth, from which 200 ml aliquots were taken and either heat-treated at
52 C for 5min or not, before being used to resuspend 1ml of E. coli donor cell pellets. The resulting suspension was spotted onto antibiotic-free Brain Heart Infusion (BHI) agar and
incubated anaerobically for 8 or 24 h. Growth on mating plates was then harvested and diluted in TY broth and plated onto BHI agar plates supplemented with D-cycloserine,
cefoxitin and thiamphenicol where appropriate. Conjugation efﬁciency was calculated as the ratio of thiamphenicol resistant CFU to total C. difﬁcile CFU. Bars represent the means of
three separate conjugations with error bars representing standard deviation. The two donor strains were compared for each condition and statistical signiﬁcance was determined
using multiple unpaired t-tests, with one asterisk denoting a (p < 0.05 *, n ¼ 3). The comparison of sExpress and CA434 with heat shock and 8 h mating plate time had a p value of
0.105.
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restriction systems which target DNA methylated at CCWGG sites.
There are numerous genetic differences between CA434 and sEx-
press other than the presence of dcm in CA434. sExpress is a B strain
derivative whereas CA434 is predominately based on K-12 strain
(96.9%) with only the remaining portion being derived from E. coli B
[34]. The hypothesis that the dcm status of the donor strain is the
salient difference in terms of conjugation efﬁciency could be clearly
examined by generating a clean deletion of dcm in the CA434 strain.
However, it seems likely that the dcm status is the most relevant
factor of this strain since in the Type IV knockout strain of
C. sporogenes NCIMB 10696, sExpress exhibited no signiﬁcant dif-
ference in conjugation efﬁciency compared to CA434; suggesting
that the only beneﬁt sExpress did have was via avoidance of the
Type IV restriction system. This result implies that C. sporogenes
CLSPO_c06750 encodes a Type IV, cytosine-acting restriction sys-
tem and that no other cytosine-acting Type IV restriction systems
are present in the C. sporogenes NCIMB 10696 genomewhich target
Dcm methylated DNA. It is possible that a circumvention of the
remaining restriction systems of C. sporogenes NCIMB10696 will
improve DNA transfer further. In particular, the Type I restriction
system encoded by the loci CLSP_c17010-CLSPO_c17030 may
represent a signiﬁcant restriction barrier which could be overcome
by the generation of a knockout strain for this region, or by the
mimicking of the methylation pattern encoded by the methyl-
transferase of the complex.
The importance of Dam/Dcmmethylation may not be due to the
effect of Type IV restriction systems in all cases. In Bacillus anthracis
it was found that knocking out all of the putative Type IV systems
improved transformation frequency with Dam þ Dcm þ DNA and
yet Dcm- Dam- DNA still transformed with greater efﬁciency [11].
With no more obvious Type IV targets it was thought more likely
that there must be an alternative mechanism by which methylated
DNA is less able to transform B. anthracis. This phenomenon is alsodocumented in both Dam-strains of E. coli [35] and Salmonella
enterica [36] which are easily transformed by unmethylated DNA
and suffer efﬁciency losses with Dam methylated DNA. Plasmids
with Dam þ Dcm þ methylation entering a recipient strain which
lacks dam and dcm methyltransferases will form hemimethylated
products after their ﬁrst replication cycle. Hemimethylated DNA
has been shown to be a poor substrate for DNA replication in dam-
E. coli strains where hemimethylated plasmids accumulate [35].
Perhaps the efﬁciency gains by avoiding Dcm methylation are not
entirely due to avoidance of Type IV systems but due to a more
suitable substrate for further replication cycles after the ﬁrst
replication event. In addition, a dam-donor strain could confer
beneﬁt even to strains which lack any adenine-directed Type IV
systems. The creation of such a strain would be of interest to help
deduce the speciﬁcity of the Type IV systems of these species. One
downside of dam- E. coli strains is that they exhibit signiﬁcantly
higher mutation rates due to the dependence of the mismatch
repair mechanism on adenine-methylated DNA [37].
Improved DNA transfer rates will facilitate genetic studies in
Clostridium species. There are species of interest for which no
established DNA transfer protocol exist such as C. carboxidivorans
and C. scindens, and there are many more species where mutant
generation procedures would beneﬁt from an improved DNA
transfer rate. For instance an I-SceI mediated gene modiﬁcation
strategy was limited by transformation rates and optimization of
this step was explicity called for [38]. The restriction systems of an
organism can be predicted from a genome sequence. The online
resource REBASE provides information on the restriction systems of
many organisms allowing a strategy to circumvent these systems to
be produced [21]. Single Molecule Real Time sequencing techniques
allow the identiﬁcation of modiﬁed bases and hence the identiﬁ-
cation of motifs which are methylated for a given genome. This
information is invaluable in the analysis of the restriction systems
of an organism and is available in the REBASE databases in many
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organisms C. autoethanogenum DSM 10061, C. sporogenes NCIMB
10696 and C. difﬁcile R20291. It is likely that the beneﬁts of using
this donor over CA434 will extend to many similar species which
have cytosine directed Type IV restriction systems. REBASE can be
used to predict the presence of these Type IV systems, in cases
where SMRT sequencing data has revealed DNA modiﬁcations the
relevance of various restriction systems is especially notable. In
cases where DNA transfer is especially difﬁcult to achieve it may be
necessary to completely mimic the DNAmodiﬁcation pattern of the
host strain. This can be achieved by cloning the host methyl-
transferase genes into a conjugal or DNA preparation shuttle strain.
The method used to generate the C. sporogenes DCLSPO_c06750
strain can be a valuable tool to generate in frame deletions of any
gene previously targeted with ClosTron. One of the main con-
straints of the CRISPR-Cas9 technology is that it strongly depends
on an efﬁcient sgRNA. This was demonstrated by the fact that of the
three seed sequences tested in this study only sgRNA 3 (50-TGGA-
TATTCACCGAACACTA-30) provided sufﬁcient counter-selective
pressure to allow the isolation of in-frame deletion mutants. This
sgRNA targets the ermB gene from the ClosTron insert, meaning it
can efﬁciently target any ClosTron-containing gene. Given the
prevalence of ClosTron mutants described in the literature and the
common desire to convert a ClosTron mutant into a clean deletion
mutant, it is hoped that the description of this effective guide re-
gion will prove of beneﬁt to researchers wanting to undertake this
task.
4. Materials and methods
4.1. Growth of bacterial strains
Escherichia coli species were routinely cultured in LB broth with
appropriate antibiotic selection unless otherwise stated. Broth
cultures were propagated in a shaking incubator at 37 C under 225
RPM, while agar plates were incubated statically at 37 C. Clos-
tridium autoethanogenum DSM 10061 was propagated in YTF me-
dium (10 g L1 yeast extract, 16 g L1 tryptone, 10 g L1 fructose,
0.2 g L1 sodium chloride, pH 5.8e6). YTF was supplemented with
appropriate antibiotic selection, and incubated in a Don Whitley
anaerobic workstation under an atmosphere of 80% nitrogen, 10%
carbon dioxide, 10% hydrogen at 37 C. Additional clostridial strains
were also incubated under these anaerobic conditions. Clostridium
difﬁcile strains were propagated on brain heart infusion medium
supplemented with 5 g.L1 yeast extract and 0.1% L-cysteine (BHIS).
Clostridium sporogenes strains were propagated on TYG medium
(20 g L1 trypticase, 5 g L1 peptone, 1 g L1 glucose, 5 g L1 yeast
extract and 1 g L1 cysteine-HCl). Growthmediawas supplemented
with antibiotics at the following working concentrations; chlor-
amphenicol (25 mgml1), thiamphenicol (15 mgml1), D-cyclo-
serine (250 mgml1), spectinomycin (100 mgml1), kanamycin
50 mgml1, tetracycline (10 mgml1). cefoxitin (10 mgml1).
4.2. Generation of the sExpress conjugal donor
A novel conjugal donor strain was created via conjugal transfer
of the plasmid R702 from CA434 into the E. coli strain NEB Express.
The genotype of NEB Express is: fhuA2 [lon] ompT gal sulA11 R(mcr-
73:miniTn10–TetS)2 [dcm] R(zgb-210:Tn10–TetS) endA1 D(mcrC-
mrr)114:IS10. Two 5ml LB broth cultures were inoculated with
donor (CA434) and recipient (NEB Express) strains respectively
from glycerol stocks, and following overnight incubation were sub-
cultured into fresh medium and grown to an OD600 of approxi-
mately 0.2. Donor and recipient cultures were incubated statically
together for one hour at 37 C, before being transferred to M9 saltsminimal medium lacking leucine and proline but supplemented
with all other required amino acids at 100mgml1 to select against
the donor CA434 and supplemented with tetracycline to select for
R702. Transconjugants were re-streaked on the same selective
media and screened for the presence of R702 and identity as NEB
Express, through acquisition of antibiotic resistance and absence of
auxotrophies, respectively. All transconjugants screened were
shown to be NEB Express cells harbouring R702 and this strain was
subsequently named sExpress.
4.3. C. autoethanogenum conjugations
A C. autoethanogenum starter culture was initiated from glycerol
stocks in non-selective YTF broth over a period of 72 h, until late
exponential phase. Prior to conjugation the culture was then sub-
cultured into fresh YTF broth (5ml) and incubated for 16e20 h,
until an OD600 of approximately 0.1e0.2 was achieved. The donor
strain harbouring the shuttle vector was inoculated into LB broth
supplemented with appropriate antibiotic selection for the marker
as present on the transferring vector well as kanamycin to continue
to select for R702, and incubated for 14e16 h. Approximately four
hours prior to conjugation the donor strain was sub-cultured into
fresh LB broth containing antibiotic selection and incubated until
an OD600 of between 0.2 and 0.4 was reached. Subsequently 1ml of
donor culture was aliquoted into a 1.5ml microcentrifuge tube
using a wide bore pipette, and centrifuged at 3000 g for three mi-
nutes. The supernatant was aspirated and discarded, and the cell
pellet gently re-suspended in 500 ml of phosphate buffered saline
(PBS) by gentle ﬂicking and inversion. The centrifugation step was
repeated, the supernatant aspirated and discarded, and the cell
pellet transferred to the anaerobic workstation. All subsequent
steps were performed under anaerobic conditions. The donor cell
pellet was gently re-suspended in 200 ml of recipient cell culture,
again through careful ﬂicking and inversion rather than by
repeated aspiration. The combined cultures were then transferred
to an anaerobic YTF agar plate without antibiotic supplementation,
spread using a wedge shaped spreader, and incubated for approx-
imately 20 h. Subsequently, 500 ml of anaerobic PBS was used to
ﬂood the surface of the agar plate, and a wedge-shaped spreader
used to gently dislodge and re-suspend the bacterial growth into
the liquid. The resultant bacterial slurry was collected by aspiration
using a pipette, and transferred to selective YTF agar plates sup-
plemented with appropriate antibiotic selection for the marker
present on the shuttle vector and D-cycloserine was used to
counter-select the E. coli donor. Transconjugant colonies of the
recipient strain should become visible following approximately
72 h of incubation, with growth rate dependant on the Gram-
positive replicon present on the shuttle vector.
4.4. DNA manipulations
Genomic DNA serving as PCR template was prepared using
genomic DNA extraction kits (Sigma Aldrich). Plasmid DNA was
prepared using Mini-prep kits (Sigma Aldrich). PCRs were carried
out using Q5 polymerase (NEB) or dreamtaq (Thermo Fisher) for
screening PCRs. Oligonucleotides were synthesised by Sigma-
Aldrich or Euroﬁns. Sanger sequencing was outsourced to Source
Bioscience (United Kingdom) or Euroﬁns (Germany). HiFi reactions
were carried out using NEBuilder® HiFi DNA Assembly Master Mix
(NEB).
4.5. C. sporogenes conjugations
Conjugations into C. sporogenes NCIMB 10696 were very similar
to C. autoethanogenum, with the following modiﬁcations:
Table 1
sgRNA seed regions used to target the ClosTron insertion.
sgRNA seed Sequence (5’/ 30)
sgRNA 1 GCAATTGCTTAAGCTGCCAG
sgRNA 2 TGCTCTGTTCCCGTATCAGC
sgRNA 3 TGGATATTCACCGAACACTA
Bold ¼ only sgRNA that proved effective.
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conjugation, the strains were sub-cultured into fresh TYG broth and
incubated for 3e4 h until an OD600 of 0.7e0.8 was achieved. Mating
cells were incubated for approximately 24 h and transconjugant
colonies were visible after approximately 20 h.
4.6. C. difﬁcile conjugations
Conjugations into C. difﬁcile R20291 were performed as for
C. autoethanogenum and C. sporogenes with several modiﬁcations:
overnight cultures of donor strains were used without subcultur-
ing, mating cells were incubated for eight hours and cefoxitin was
used alongside D-cycloserine on transconjugant selection plates.
Heat shocked conjugations were performed as detailed in Ref. [31]
which involved a 2min heat shock at 52 C prior tomixing with the
donor E. coli culture.
4.7. Generation of C. autoethanogenum DCLAU_0514
The CLAU_0514 gene was targeted using CRISPR cas9 gene
editing techniques, whereby a synthetic guide targeting a unique
sequence contained within the gene in question is supplied on a
vector conferring thiamphenicol resistance, along with a nucleo-
lytically active cas9 from Streptococcus pyogenes and a homologous
repair cassette, a knockout technique previously shown to be
effective in this organism [23]. The homology cassette was
composed of 1 kb homology arms ﬂanking CLAU_0514, assembled
by overlap extension PCR using the oligonucleotides
CLAU_0514_3’_F, CLAU_0514_3’_R, CLAU_0514_5’_F, and
CLAU_0514_5’_R, and were incorporated into a modiﬁed version of
the CRISPR cas9 vector through traditional restriction ligation
cloning methods. The synthetic guide targeting sequence was
introduced using the NEB HiFi Assembly cloning kit to incorporate a
single stranded oligonucleotide (Sigma Aldrich) into the linearised
CRISPR cas9 vector, yielding the plasmid pMTL43151-CLAU_0514.
This plasmid was veriﬁed using Sanger sequencing, transformed
into the conjugative donor strain sExpress, and conjugated into
C. autoethanogenum. Resultant colonies which harboured resis-
tance to thiamphenicol were screened at the CLAU_0514 locus for
the intended in-frame deletion, and the PCR product sequenced to
conﬁrm the nature of the deletion. Following sequence conﬁrma-
tion, plasmid loss was achieved through serial passage in the
absence of antibiotic selection, conﬁrmed through replica plating,
and the resultant strain stored at 80 C.
4.8. Generation of the C. sporogenes△CLSPO_c06750 strain
The CLSPO_c06750 gene was targeted using ClosTron [39]. This
approach allows the creation of mutants by the insertion of a group
II intron containing a retrotransposition-activated marker into a
target gene, causing loss of function by disruption of the gene. The
intronwas re-targeted using a computer algorithm available on the
website www.clostron.com [39]. A pMTL007 vector containing the
re-targeted intron (pMTL007:Csp-CLSPO_c06750-1241a) was ob-
tained from DNA2.0 Inc. The vector was electroporated into E. coli
CA434 and then conjugated into C. sporogenes NCIMB 10696 as
previously described. Transconjugants were selected on TYG plates
containing D-cycloserine and thiamphenicol, because the pMTL007
contains the catP gene in the backbone. Cells containing the intron
were selected on TYG plates containing D-cycloserine and eryth-
romycin since the ermB gene was used as the retrotransposition-
activated marker. The insertion of the intron into the
CLSPO_c06750 gene was screened by PCR and conﬁrmed by
sequencing. The mutant strain was named C. sporogenes-
CLSPO_c06750-1241a:CT.Three different sgRNA seeds targeting the ClosTron insert were
designed using Benchling software (www.benchling.com)
(Table 1). sgRNA 1 and sgRNA 3 target the ermB gene (retro-
transposition-activatedmarker), and sgRNA 2 targets the beginning
of the ClosTron insert. sgRNA cassettes including ParaE, the seed and
the fdx terminator were assembled by overlap extension PCR.
Homology arms (1 Kb each) ﬂanking the CLSPO_c06750 gene
were also designed and assembled by overlap extension PCR. These
included the ﬁrst two and last three codons of the CLSPO_c06750
gene.
The sgRNA and homology arm cassettes were incorporated into
a modiﬁed version of the CRISPR cas9 vector described previously
through traditional restriction ligation cloning methods, yielding
plasmids pMTL43151_CLSPO_c06750_sgRNA1, pMTL43151_CLSPO_
c06750_sgRNA2, and pMTL43151_CLSPO_c06750_sgRNA3 which
were sequence conﬁrmed with Sanger sequencing. The vectors
were electroporated into E. coli CA434 and then conjugated into
C. sporogenes- CLSPO_c06750-1241a:CT. Transconjugants were
selected on TYG plates containing D-cycloserine and thiamphenicol.
The in-frame deletion of the CLSPO_c06750 gene (obtained only
with sgRNA 3) was screened by PCR and conﬁrmed by sequencing.
The mutant strain was named C. sporogenes DCLSPO_c06750.4.9. Strain availability
sExpress is a deriviative of NEB Express (NEB catalog #C2523)
which means it is subject to commercial restrictions. Brieﬂy,
licensing is not required for internal research and development but
if it is used for the production of or as part of a commercial product
then commercial restrictions apply and a licensing agreement is
required. For more information about commercial rights, please
contact NEB's Global Business Development team at gbd@neb.com.Author contributions
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